St. Judes wins CE Mark for next-gen heart defibrillators

05/13/2013 | MedGadget.com

St. Jude Medical received the CE mark for its Ellipse and SJM Assura suite of implantable cardioverter defibrillators and cardiac resynchronization therapy defibrillators. The next-generation devices are used to administer high-voltage electricity to heart tissue and come with advanced coating to help lower the risk for electrode lead abrasion.

View Full Article in:

MedGadget.com

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Site Quality Management
CareFusion
Minneapolis, MN
In house Compliance Officer
Confidential
Pompano Beach, FL
Clinical Project Manager
Abiomed, Inc.
Danvers, MA
Sr. Manager, Regulatory Affairs - International
Integra LifeSciences
Plainsboro, NJ
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC